San Diego, February 5, 2026
Modular Medical, Inc. is progressing towards the launch of its Pivot™ tubeless insulin patch pump, aiming for FDA approval in the first quarter of 2026. The company has started production of validation lots for the pump’s disposable cartridge and infusion set, emphasizing its commitment to innovation in diabetes management. The Pivot system aims to simplify insulin delivery for adults reluctant to transition from traditional multiple daily injections, addressing the significant demand in the growing insulin pump market valued at around $8 billion.
Modular Medical Takes Major Steps Toward Insulin Pump Launch
San Diego-Based Modular Medical, Inc. Eyes FDA Approval for Innovative Diabetes Solution
San Diego, CA – Modular Medical, Inc. (NASDAQ:MODD), a promising player in the healthcare technology space, has made significant strides in its journey toward launching the Pivot™ tubeless insulin patch pump. By commencing production of validation lots for the pump’s disposable cartridge and infusion set, the company is on track for a commercial launch in the first quarter of 2026, pending FDA clearance. This development could potentially transform insulin delivery for adults with diabetes, particularly for those hesitant to move away from traditional multiple daily injections (MDI).
As the global insulin pump market continues its rapid expansion—currently valued at around $8 billion—the demand for innovative solutions is at an all-time high. Modular Medical’s Pivot system, as the first removable, tubeless 3ml patch pump in the industry, aims to simplify the lives of millions managing diabetes. The design not only addresses the complexities and costs often associated with current options but also presents a beacon of hope for improved accessibility and user experience.
The determination shown by local entrepreneurs to tackle healthcare challenges illustrates the incredible resilience and creativity present in San Diego’s business environment. By fostering an ecosystem that encourages innovation and reduces red tape, communities can enhance economic growth and improve health outcomes for residents.
Pivot Pump: Key Features Elevating Diabetes Management
The Pivot system is engineered to meet the specific needs of adults managing diabetes. With its full 3ml removable cartridge and a user-friendly interface, the pump targets a significant segment of the diabetic population, particularly those reluctant to utilize insulin pumps due to perceived difficulties.
Manufacturing Milestone
Initiating validation production lots for the cartridge and infusion set marks a pivotal manufacturing milestone for Modular Medical. This achievement not only derisks commercial-scale production but also bolsters the company’s overall strategy and trust in its ability to deliver a high-quality product when it hits the market.
Market Potential and Innovation
The insulin pump sector is ripe for innovation, and Modular Medical is well-positioned to capitalize on this growth. By focusing on a differentiated, patient-centric product, the company is demonstrating how localized efforts can lead to substantial effects on public health, ultimately contributing to the broader San Diego County economy. The Pivot pump’s user-friendly design could encourage wider adoption, facilitating improved diabetes management for individuals who have thus far been hesitant.
Path to FDA Clearance
While the Pivot Insulin Delivery System is not currently cleared for sale by the FDA, Modular Medical’s proactive approach to production means it is taking essential steps to secure the necessary approvals. Transitioning from concept to market requires significant regulatory diligence, and where possible, reducing delays in the approval process can amplify the impact of such medical innovations.
CEO Insights
Local business leaders like CEO Jeb Besser understand the importance of this gateway towards commercial launch, expressing enthusiasm over achieving critical validation milestones. This leadership perspective highlights a broader commitment to innovation in the healthcare sector and the associated benefits that arise from proactively addressing patient needs.
Conclusion
Modular Medical’s advancements with the Pivot tubeless insulin patch pump underscore a rising tide of entrepreneurial spirit in San Diego, which is essential for driving economic growth. With impending FDA clearance, the potential for this innovative product to impact lives positively cannot be overstated. As we look ahead, local residents and stakeholders are encouraged to support such initiatives that not only promise to elevate health outcomes but also bolster the San Diego County economy.
Frequently Asked Questions (FAQ)
What is the Pivot tubeless insulin patch pump?
The Pivot system is the industry’s first removable, tubeless 3ml patch pump, designed to simplify insulin delivery for adults with diabetes who are hesitant to transition from multiple daily injections (MDI) due to cost and complexity. This product targets a substantial segment of the growing global insulin pump market, valued at approximately $8 billion.
When is the Pivot pump expected to launch?
Modular Medical has commenced production of validation lots for the Pivot pump’s disposable cartridge and infusion set, marking a significant step toward its planned commercial launch in the first quarter of 2026, pending FDA clearance.
What are the key features of the Pivot pump?
The Pivot pump features a full 3ml removable cartridge and a user-friendly interface, aiming to enhance access to insulin therapy for millions managing diabetes with MDI, offering significant clinical therapy improvements.
Is the Pivot pump currently available for sale?
The Pivot Insulin Delivery System is not currently cleared for sale by the FDA.
Key Features of the Pivot Tubeless Insulin Patch Pump
| Feature | Description |
|---|---|
| Design | Removable, tubeless 3ml patch pump |
| Target Audience | Adults with diabetes hesitant to transition from multiple daily injections (MDI) due to cost and complexity |
| Market Potential | Targets a substantial segment of the growing global insulin pump market, valued at approximately $8 billion |
| Key Features | Full 3ml removable cartridge and user-friendly interface |
| Launch Timeline | Planned commercial launch in the first quarter of 2026, pending FDA clearance |
| FDA Status | Not currently cleared for sale by the FDA |
Deeper Dive: News & Info About This Topic
HERE Resources
San Diego State Guard Inspires with Type 1 Diabetes Journey
Author: STAFF HERE SAN DIEGO WRITER
The SAN DIEGO STAFF WRITER represents the experienced team at HERESanDiego.com, your go-to source for actionable local news and information in San Diego, San Diego County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Comic-Con International, San Diego County Fair, and San Diego Pride Festival. Our coverage extends to key organizations like the San Diego Regional Chamber of Commerce and United Way of San Diego County, plus leading businesses in biotechnology, healthcare, and technology that power the local economy such as Qualcomm, Illumina, and Scripps Health. As part of the broader HERE network, including HEREAnaheim.com, HEREBeverlyHills.com, HERECostaMesa.com, HERECoronado.com, HEREHollywood.com, HEREHuntingtonBeach.com, HERELongBeach.com, HERELosAngeles.com, HEREMissionViejo.com, and HERESantaAna.com, we provide comprehensive, credible insights into California's dynamic landscape.
